Page last updated: 2024-12-05

allyl isocyanate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

allyl isocyanate: a glycosinolate degradation product that has insectidical activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15123
CHEBI ID192403
MeSH IDM0473315

Synonyms (32)

Synonym
3-isocyanato-1-propene
1476-23-9
nsc96964
allyl isocyanate
isocyanic acid, allyl ester
1-propene, 3-isocyanato-
wln: ocn2u1
propene, 3-isocyanato-
nsc-96964
BB 0260144
nsc 96964
brn 0506106
inchi=1/c4h5no/c1-2-3-5-4-6/h2h,1,3h
allyl isocyanate, 98%
3-isocyanatoprop-1-ene
STK503764
AKOS005141683
CHEBI:192403
unii-dk4cju9mcx
dk4cju9mcx ,
FT-0615921
prop-1-en-3yl isocyanate
2-propenyl isocyanate
prop-1-en-3-yl isocyanate
allylisocyanate
DTXSID8061719
mfcd00002044
J-008376
F2190-0558
F81512
EN300-148061
?allyl isocyanate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isocyanatesOrganonitrogen compounds that are derivatives of isocyanic acid; compounds containing the isocyanate functional group -N=C=O (as opposed to the cyanate group, -O-C#N).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (42.31)29.6817
2010's15 (57.69)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.97 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index83.44 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]